Safety Study of Albuterol Spiromax® in Subjects With Asthma
Public ClinicalTrials.gov record NCT01698320. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center 52-Week Study to Assess the Safety of Albuterol Spiromax® in Subjects With Asthma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety of Albuterol Spiromax® over 52 weeks during two dosing periods: (1) a 12-week, double-blind, placebo-controlled QID dosing period followed by (2) a 40-week, open-label PRN dosing period, and to evaluate Albuterol Spiromax® device performance through the life of the device during the study.
Study identification
- NCT ID
- NCT01698320
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 364 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2012 (Type not available)
- Primary completion
- Dec 2013 (Actual)
- Completion
- Dec 2013 (Actual)
- Last update posted
- Aug 19, 2015
2012 – 2013
United States locations
- U.S. sites
- 30
- U.S. states
- 18
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 10169 | Huntington Beach | California | — | — |
| Teva Investigational Site 10157 | San Diego | California | — | — |
| Teva Investigational Site 10148 | Denver | Colorado | — | — |
| Teva Investigational Site 10159 | Denver | Colorado | — | — |
| Teva Investigational Site 10158 | Miami | Florida | — | — |
| Teva Investigational Site 10168 | Miami | Florida | — | — |
| Teva Investigational Site 10154 | Gainesville | Georgia | — | — |
| Teva Investigational Site 10161 | Louisville | Kentucky | — | — |
| Teva Investigational Site 10162 | Bethesda | Maryland | — | — |
| Teva Investigational Site 10166 | Wheaton | Maryland | — | — |
| Teva Investigational Site 10151 | Minneapolis | Minnesota | — | — |
| Teva Investigational Site 10142 | Plymouth | Minnesota | — | — |
| Teva Investigational Site 10152 | St Louis | Missouri | — | — |
| Teva Investigational Site 10146 | Bellevue | Nebraska | — | — |
| Teva Investigational Site 10160 | Skillman | New Jersey | — | — |
| Teva Investigational Site 10144 | Rochester | New York | — | — |
| Teva Investigational Site 10141 | High Point | North Carolina | — | — |
| Teva Investigational Site 10153 | Raleigh | North Carolina | — | — |
| Teva Investigational Site 10147 | Canton | Ohio | — | — |
| Teva Investigational Site 10143 | Cincinnati | Ohio | — | — |
| Teva Investigational Site 10167 | Sylvania | Ohio | — | — |
| Teva Investigational Site 10150 | Eugene | Oregon | — | — |
| Teva Investigational Site 10156 | Portland | Oregon | — | — |
| Teva Investigational Site 10155 | El Paso | Texas | — | — |
| Teva Investigational Site 10149 | New Braunfels | Texas | — | — |
| Teva Investigational Site 10145 | San Antonio | Texas | — | — |
| Teva Investigational Site 10170 | San Antonio | Texas | — | — |
| Teva Investigational Site 10163 | Burke | Virginia | — | — |
| Teva Investigational Site 10165 | Seattle | Washington | — | — |
| Teva Investigational Site 10164 | Greenfield | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01698320, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 19, 2015 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01698320 live on ClinicalTrials.gov.